Spinal Cord Injuries: Clinical Trials

70 trials for Spinal Cord Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

43 completed, 8 unknown, 6 terminated, 5 recruiting. 70 Phase 3, 31 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 370Completed 43, Unknown 8, Terminated 6, Recruiting 5, Withdrawn 3, Active not recruiting 2, Suspended 2, Not yet recruiting 1
Phase 231Completed 17, Recruiting 4, Terminated 4, Unknown 2, Active not recruiting 1, Not yet recruiting 1, Suspended 1, Withdrawn 1

Follow Spinal Cord Injuries: new trials by email Literature Review of Spinal Cord Injuries trials Research Report on Spinal Cord Injuries

Trials (filtered) newest first · largest first

All 70 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial
testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries
Phase 2 / Phase 3Not yet recruitingVA Office of Research and Development3002027-10-012026-08-04
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Galantamine Hydrobromide Extended Release - Spinal Cord Injury, Traumatic Spinal Cord Injury
Phase 2 / Phase 3RecruitingNorthwell Health602026-06-152026-06-04
Transcutaneous Spinal Cord Stimulation for Upper Extremity Function
Transcutaneous spinal cord stimulation, Upper extremity rehabilitation - Spinal Cord Injuries, Stroke
Phase 2 / Phase 3RecruitingUniversity of Alberta302024-06-152026-04-13
Improvement of Reproductive Function in Men With Spinal Cord Injury (SCI)
Probenecid 500 Milligrams (mg), probenecid 250 Milligrams (mg), Placebo - Infertility, Male
Phase 3RecruitingUniversity of Miami902024-01-182026-03-02
Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury
Placebo diet, Anti-inflammatory diet, Nabilone Capsules - Spinal Cord Injuries, Neuropathic Pain
Phase 3CompletedEldon Loh, MD142023-03-012025-07-22
Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
brivaracetam, Placebo - Spinal Cord Injuries, Neuropathic Pain
Phase 3CompletedUniversity of Minnesota442023-01-012026-03-18
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Vibegron - Neurogenic Detrusor Overactivity
Phase 2 / Phase 3RecruitingUrovant Sciences GmbH712022-10-122026-06-15
Stem Cells in Spinal Cord Injury
Neuro-Cells - Spinal Cord Injuries, Acute Spinal Cord Injury
Phase 2 / Phase 3UnknownNeuroplast162022-01-182023-09-29
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
NMES, Vitamin D, Passive movement - Spinal Cord Injury
Phase 2 / Phase 3CompletedVA Office of Research and Development62021-10-012026-01-23
Vitamin D Supplementation in Individuals With a Chronic Spinal Cord Injury
Cholecalciferol (Vitamin D3), Placebo - Spinal Cord Injuries, Vitamin D Deficiency
Phase 3CompletedSwiss Paraplegic Research, Nottwil502021-05-192024-03-08
Epidural Stimulation and Resistance Training After SCI
Exoskeletal assisted walking, Epidural Stimulation, Resistance Training - Spinal Cord Injuries
Phase 2 / Phase 3RecruitingUnited States Department of Defense202021-02-032026-01-02
Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction
Human Milk Oligosaccharides (HMO), Placebo - Spinal Cord Injuries, Neurogenic Bowel
Phase 3CompletedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's302021-01-272023-12-13
Neostigmine and Glycopyrrolate by Iontophoresis
Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation
Phase 3Active not recruitingJames J. Peters Veterans Affairs Medical Center62020-11-062024-04-08
Effects of 5HTP on the Injured Human Spinal Cord
5-Hydroxytryptophan 100 MG, 5-Hydroxytryptophan, Carbidopa - Spinal Cord Injuries
Phase 2 / Phase 3Active not recruitingUniversity of Alberta62020-07-012026-09-16
High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients.
4-Aminopyridine, Placebo oral capsule - Spinal Cord Injuries, Chronic
Phase 3UnknownCoordinación de Investigación en Salud, Mexico1502019-07-172021-02-21
Effects of 5HTP and LDOPA on CNS Excitability After SCI
5HTP, L-DOPA, Placebo oral tablet - Spinal Cord Injuries
Phase 2 / Phase 3SuspendedJessica M D'Amico302019-06-192022-10-17
Gentamicin Bladder Instillations to Prevent Urinary Tract Infections in Patients With Spinal Cord Injury
Gentamicin Sulfate - Urinary Tract Infections, Spinal Cord Injuries
Phase 2 / Phase 3CompletedUniversity of Michigan232018-08-242024-06-25
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury
ES135 - Spinal Cord Injuries
Phase 3SuspendedEusol Biotech Co., Ltd.1602018-03-072024-05-08
The Effect of Gabapentin Used as a Preemptive to the Emergence and Development Chronic Neuropathic Pain in Patients After Spinal Cord Trauma
Gabapentin, Metamizol, Tramadol - Chronic Pain Due to Trauma, Spinal Cord Injuries
Phase 3WithdrawnMasaryk University2017-10-012019-03-07
Treatment of Post-SCI Hypotension
Midodrine Hydrochloride - Spinal Cord Injury, Autonomic Dysreflexia
Phase 2 / Phase 3CompletedJames J. Peters Veterans Affairs Medical Center662017-06-012025-02-21

Showing 20 of 70. Sign in to see all of them.

Narrower conditions

Quadriplegia (10)  ·  Paraplegia (7)  ·  Neuralgia (6)  ·  Pain (4)  ·  Spinal Cord Compression (4)  ·  Spinal Cord Diseases (4)  ·  Wounds and Injuries (4)  ·  Hypotension, Orthostatic (3)  ·  Muscle Spasticity (3)  ·  Stroke (3)  ·  Bone Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Erectile Dysfunction (2)  ·  Hypogonadism (2)

Broader conditions

Nervous System Diseases (69)  ·  Central Nervous System Diseases (68)  ·  Spinal Cord Diseases (66)  ·  Trauma, Nervous System (66)  ·  Wounds and Injuries (66)  ·  Pathological Conditions, Signs and Symptoms (32)  ·  Signs and Symptoms (30)  ·  Neurologic Manifestations (25)  ·  Paralysis (10)  ·  Cardiovascular Diseases (8)  ·  Vascular Diseases (8)  ·  Immune System Diseases (7)  ·  Neuromuscular Diseases (7)  ·  Peripheral Nervous System Diseases (7)  ·  Male Urogenital Diseases (6)

Interventions

4-Aminopyridine (3)  ·  Pregabalin (3)  ·  Zoledronic Acid (3)  ·  Carbidopa (2)  ·  Cholecalciferol (2)  ·  Denosumab (2)  ·  Methylprednisolone (2)  ·  Midodrine (2)  ·  NG-Nitroarginine Methyl Ester (2)  ·  Resistance Training (2)  ·  Risedronic Acid (2)  ·  5-Hydroxytryptophan (1)  ·  Botulinum Toxins, Type A (1)  ·  Cell- and Tissue-Based Therapy (1)  ·  Curcumin (1)

Sponsors

VA Office of Research and Development (6)  ·  James J. Peters Veterans Affairs Medical Center (3)  ·  US Department of Veterans Affairs (3)  ·  University of Alberta (3)  ·  Acorda Therapeutics (2)  ·  Amgen (2)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (2)  ·  Thomas Jefferson University (2)  ·  Toronto Rehabilitation Institute (2)  ·  University of Melbourne (2)  ·  University of Miami (2)  ·  AOSpine North America Research Network (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Barth Wilsey (1)

Countries

United States (39)  ·  Canada (17)  ·  Australia (5)  ·  Japan (4)  ·  Czechia (3)  ·  New Zealand (3)  ·  Spain (3)  ·  China (2)  ·  Denmark (2)  ·  Hong Kong (2)  ·  Ireland (2)  ·  Italy (2)  ·  Lithuania (2)  ·  Malaysia (2)  ·  Philippines (2)

Top investigators

Jessica D'Amico, PhD (3)  ·  B. Cathy Craven, MD, FRCPC (2)  ·  William Bauman, MD (2)  ·  Andrea L Behrman, PhD (1)  ·  Andrea Townson, Dr. (1)  ·  Andrew Blight (1)  ·  Andrew Blight, MD (1)  ·  Anke Scheel-Sailer, Dr. med. (1)  ·  Anne Pelletier-Cameron, MD (1)  ·  Antonio Oliviero, MD (1)  ·  Antonio Oliviero, MD, PhD (1)  ·  Arthur Prochazka (1)  ·  Ashraf Gorgey, PhD PT (1)

Results publications

PMID 27448285, PMID 16398945, PMID 17046161, PMID 17213237, PMID 17385265, PMID 17475549, PMID 17965289, PMID 19618698, PMID 19648013, PMID 19651280, PMID 19799783, PMID 20012982, PMID 21252493, PMID 21372246, PMID 21674390, PMID 21675354, PMID 21717386, PMID 21762873, PMID 22975218, PMID 22985379, PMID 23295632, PMID 23343764, PMID 23345639, PMID 23700789, PMID 23975226, PMID 24968251, PMID 25114584, PMID 25976743, PMID 26093811, PMID 26394202, PMID 26545369, PMID 26705884, PMID 27008910, PMID 27611736, PMID 27901413, PMID 28072797, PMID 28414254, PMID 28464732, PMID 28864949, PMID 28948164, PMID 28970100, PMID 29972647, PMID 30794084, PMID 30845047, PMID 31518978, PMID 32157242, PMID 32203065, PMID 32352341, PMID 33177997, PMID 33443609

NIH funding

R01DA030424 (1), R01HD056267 (1)